Wirtschaftlich, wirksam und sicher - Optimal im Kampf gegen methicillinresistente Staphylococcus aureus

Der Klinikarzt 2006; 35(11): XII
DOI: 10.1055/s-2006-958474

Blickpunkt

Literatur

01 Weigelt JA . Itani KM . Li JZ . Linezolid (LZD) reduces LOS when compared to Vancomycin (Vanco) for complicated skin and soft tissue infections (cSSTI) due to suspected or proven MRSA: results from a randomised trial. ISDA. 2003; Poster Session 41 "Antimicrobials: Resistance and Susceptibility" Poster 315
02 Weigelt JA . Itani KM . Lau WK . et al . Linezolid (LZD) vs Vancomycin (Vanco) in the treatment of complicated skin and soft tissue infections (cSSTI): clinically significant outcome differences. ISDA. 2003; Poster Session 41 "Antimicrobials: Resistance and Susceptibility" Poster 314
03 Weigelt JA . Kaafarani HM . Itanie KM . Swanson RN . Linezolid eradicates MRSA better than vancomycin from surgical-site infections. Am J Surg. 2004; 188 760-766